Ono Pharmaceutical Co., Ltd.
OTC: OPHLF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Gyo Sagara
- Employees
- 3,853
- Headquarters
- Osaka, Japan
- IPO year
- 2013
- Market cap
- $6.3B
- Website
- https://www.ono-pharma.com
Loading OPHLF…
Loading profile data…Frequently asked questions about OPHLF
What does Ono Pharmaceutical Co., Ltd. (OPHLF) do?
Globally, Ono Pharmaceutical Co., Ltd., along with its affiliated entities, is engaged in the development, procurement, and commercialization of pharmaceutical products and diagnostic tools. Its product line features a wide array of therapeutic solutions, including several key oncology treatments such as OPDIVO, KYPROLIS, MEKTOVI, VELEXBRU, ADLU...
Where does OPHLF trade?
Ono Pharmaceutical Co., Ltd. (OPHLF) trades on the Other OTC.
What sector is OPHLF in?
Ono Pharmaceutical Co., Ltd. (OPHLF) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Ono Pharmaceutical Co., Ltd.?
Gyo Sagara is the chief executive officer of Ono Pharmaceutical Co., Ltd. (OPHLF).
Where is Ono Pharmaceutical Co., Ltd. headquartered?
Ono Pharmaceutical Co., Ltd. is headquartered in Japan.
Does OPHLF pay a dividend?
Yes — Ono Pharmaceutical Co., Ltd. (OPHLF) paid a trailing twelve-month dividend of USD 0.52 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did OPHLF go public?
Ono Pharmaceutical Co., Ltd. (OPHLF) completed its initial public offering in 2013.